These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24499082)

  • 61. Impact of sevelamer hydrochloride on serum magnesium concentrations in hemodialysis patients.
    Ikee R; Toyoyama T; Endo T; Tsunoda M; Hashimoto N
    Magnes Res; 2016 Apr; 29(4):184-190. PubMed ID: 27965186
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients.
    Ikee R; Tsunoda M; Sasaki N; Sato N; Hashimoto N
    Int Urol Nephrol; 2013 Jun; 45(3):839-45. PubMed ID: 22684797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Images of the Month: Gastric Pneumatosis Due to Sevelamer-Mediated Necrosis.
    Amer S; Nguyen C; DePetris G
    Am J Gastroenterol; 2015 Jun; 110(6):799. PubMed ID: 26052763
    [No Abstract]   [Full Text] [Related]  

  • 64. [Sevelamer:hydrochloride].
    Hyodo T; Taira T; Wakai H; Takemura T; Yamamoto S; Yashida K; Baba S
    Clin Calcium; 2005 Jan; 15(1):61-70. PubMed ID: 15632474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive factors of low HCO3- levels in peritoneal dialysis patients.
    Kasimatis E; Maksich D; Jassal V; Bargman JM; Oreopoulos DG
    Clin Nephrol; 2005 Apr; 63(4):290-6. PubMed ID: 15847256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden].
    Mitsuboshi S; Yamada H; Nagai K; Okajima H
    Yakugaku Zasshi; 2018; 138(1):135-139. PubMed ID: 29311459
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005).
    Yang JY; Lee TC; Montez-Rath ME; Desai M; Winkelmayer WC
    J Nephrol; 2013; 26(2):281-8. PubMed ID: 22419235
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sevelamer carbonate markedly reduces levothyroxine absorption.
    Iovino M; Iovine N; Petrosino A; Giagulli VA; Licchelli B; Guastamacchia E; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2014; 14(3):206-9. PubMed ID: 25183496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Does Sevelamer reduce mortality by slowing of progression of coronary calcification?
    Badve SV; Magner PO
    Kidney Int; 2007 Jun; 71(12):1328-9. PubMed ID: 17554361
    [No Abstract]   [Full Text] [Related]  

  • 70. Levothyroxine and sevelamer: listen to the patient.
    Granata A; Floccari F; Gallieni M
    Endocr Pract; 2011; 17(6):961-2. PubMed ID: 22299156
    [No Abstract]   [Full Text] [Related]  

  • 71. Successful recovery from iatrogenic severe hypernatremia and severe metabolic acidosis resulting from accidental use of inappropriate bicarbonate concentrate for hemodialysis treatment.
    Bhosale GP; Shah VR
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):107-10. PubMed ID: 25579726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucose-Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients.
    Ikee R; Hashimoto N
    Ther Apher Dial; 2015 Aug; 19(4):412-3. PubMed ID: 25810123
    [No Abstract]   [Full Text] [Related]  

  • 73. Gastrointestinal symptoms after the substitution of sevelamer hydrochloride with lanthanum carbonate in Japanese patients undergoing hemodialysis.
    Suzuki D; Ichie T; Hayashi H; Sugiura Y; Sugiyama T
    Pharmazie; 2015 Aug; 70(8):522-6. PubMed ID: 26380521
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Daily variability of acid-base status and determinants of serum bicarbonate in hemodialysis patients.
    Ozdemir A; Yucel Kocak S; Apaydın S; Yılmaz M
    Clin Nephrol; 2022 Jul; 98(1):26-32. PubMed ID: 35343436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A bitter pill to swallow.
    David S; Merscher S; Schmidt-Guertler H; Kielstein JT; Kirchhoff T; Meier M
    Clin Nephrol; 2009 Oct; 72(4):319-21. PubMed ID: 19825340
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sevelamer hydrochloride in peritoneal dialysis patients: ca' canny but ca' awa'.
    Garland JS; Morton AR
    Perit Dial Int; 2006; 26(3):300-5. PubMed ID: 16722019
    [No Abstract]   [Full Text] [Related]  

  • 77. Lower gastrointestinal bleeding: association with Sevelamer use.
    Madan P; Bhayana S; Chandra P; Hughes JI
    World J Gastroenterol; 2008 Apr; 14(16):2615-6. PubMed ID: 18442219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapy of Intradialytic Chronic Metabolic Acidosis in Germany - Is it According to Latest Evidence?].
    Geiger H; Jung O
    Dtsch Med Wochenschr; 2017 Jul; 142(13):e89-e94. PubMed ID: 28672414
    [No Abstract]   [Full Text] [Related]  

  • 79. Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder.
    Gallieni M; Cozzolino M; Brancaccio D
    Kidney Int; 2000 Apr; 57(4):1776-7. PubMed ID: 10809607
    [No Abstract]   [Full Text] [Related]  

  • 80. Concordance analysis between dosed serum bicarbonate and that calculated by gas analysis in chronic renal patients.
    Andrade LGM; Muniz AB; Mondelli AL; Ponce D
    J Bras Nefrol; 2020; 42(4):478-481. PubMed ID: 32406476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.